Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant

Clinical trial NCT03328936 · WITHDRAWN

Trial details

NCT number: NCT03328936
Sponsor: Ohio State University Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Cell Transplantation Recipient Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2018-09-01
Primary completion: 2021-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.